Eisai, Biogen get U.S. FDA approval for Alzheimer’s drug, apply for full approval – Reuters
Eisai, Biogen get U.S. FDA approval for Alzheimer’s drug, apply for full approval Reuters FDA Approves, Leqembi, New Treatment for Early Alzheimer’s The New York Times FDA greenlights new Alzheimer’s drug amid safety concerns NBC News Alzheimer’s drug lecanemab receives accelerated approval amid safety concerns CNN New Alzheimer’s drug offers hope to patients and caregivers | DW News DW News